Stock Ratings / Consumer Discretionary / AHG / earnings

RSKD (53) QNST (73) LQDT (72) NUTX (75) ⌘ Pro Terminal →

Akso Health Group ADS (AHG) Next Earnings Date & Expected ±12.5% Move

$1.33 +2.31% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Akso Health Group ADS (AHG) carries a Roarable Rating of D- (Sell) with 41/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $1.14B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-7.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AHG)Realized 20D OHLCV Swing Band: ±12.5%

NEXT EST. WINDOW: Dec 29, 2026 (~57 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.17 Expected Swing

MODEL EARNINGS SETUP GAUGE

AHG Quantitative Pre-Earnings Setup: 41/100

Trailing EPS: $4.25 • YoY Revenue Growth: -6.4%

Model Bullish Setup (41/100)Model Risk Weight (59/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2026-03-31	$13.8M	-$18.7M	-$12.8M	-0.1%
FY 2024	2025-03-31	$14.8M	-$135.0M	$1.0M	-1.9%
FY 2023	2024-03-31	$2.4M	-$9.5M	$1.4M	8%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AHG)

✓Walkthrough of AHG's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

AHG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -39.27%▼ DESCENDING CHANNEL

2026-10-30O $1.26H $1.33L $1.24C $1.33VOL 4.9K

RES: $1.49SUP: $0.50SMA50: $1.02SMA200: $1.51

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AHG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AHG Butterfly Map → + Track AHG →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -6.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AHG today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AHG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AHG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AHG)

Consumer Discretionary Rank #806 of 1011 ⚔️ RSKD vs AHG Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (AHG vs. RSKD, QNST, LQDT, NUTX)

Industry: Business Services (90 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Akso Health Group ADS (AHG) ranks #806 by composite RQD confidence (41/100, grade D-) and #499 by equity capitalization ($1.14B). Within this direct 5-issuer industry benchmark cohort, NUTX leads on earnings valuation at 20.3x trailing P/E, while NUTX leads on capital efficiency and profitability with 85.0% ROIC and 50.8% gross margin. NUTX currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with AHG at 41/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
AHG ACTIVE Akso Health Group ADS	D-	41/100	—	-0.1%	—	+2.31%	$1.14B	Benchmark Subject
RSKD Riskified Ltd. (Class A)	D+	53/100	—	51.7%	-20.3%	-0.55%	$1.22B	/rskd-vs-ahg →
QNST QuinStreet Inc.	B	73/100	—	10.1%	2.6%	+4.83%	$980.8M	/qnst-vs-ahg →
LQDT Liquidity Services Inc.	B	72/100	50.5x	43.8%	12.9%	+3.32%	$1.42B	/lqdt-vs-ahg →
NUTX Nutex Health Inc.	B	75/100	20.3x	50.8%	85.0%	-1.19%	$1.44B	/nutx-vs-ahg →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001702318

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Akso Health Group ADS (AHG) reported GAAP revenue of $13.8M (-6.4% vs. FY2024 revenue of $14.8M , and +472.9% cumulative change since FY2023) , GAAP net income of -$18.7M, operating cash flow of -$12.8M, and free cash flow of -$12.8M (-1350.9% YoY). On the balance sheet, AHG closed FY2025 with $212.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-03-31	$13.8M	-$18.7M	-$12.8M	-$12.8M	$212.0M	—
FY2024 (FY)	2025-03-31	$14.8M	-$135.0M	$1.2M	$1.0M	—	—
FY2023 (FY)	2024-03-31	$2.4M	-$9.5M	$1.4M	$1.4M	—	—

3. AHG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AHG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Akso Health Group ADS (NASDAQ: AHG) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 41/100 at a spot price of $1.33 (+2.31% 1D, market cap $1.14B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, AHG ranks #806 in composite RQD confidence.

How does AHG compare to RSKD and QNST in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Business Services), AHG carries a Roarable D- (41/100 RQD), trailing P/E of N/A, gross margin of -0.1%, and ROIC of —. By comparison, RSKD (Riskified Ltd. (Class A)) holds a D+ grade (53/100 RQD, P/E N/A, ROIC -20.3%, cap $1.22B) and QNST (QuinStreet Inc.) posts a B grade (73/100 RQD, P/E N/A, ROIC 2.6%, cap $980.8M). Among the 5-stock peer group, NUTX leads on earnings multiple (20.3x) while NUTX leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AHG?

Per AHG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001702318), Akso Health Group ADS generated $13.8M in revenue (-6.4% YoY), -$18.7M in net income, and -$12.8M in free cash flow against $212.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AHG trading relative to its 50-day, 200-day, and 52-week technical levels?

AHG last traded at $1.33 (+2.31% on volume of 33,069 shares), positioning the stock +30.39% above its 50-day simple moving average ($1.02) and -11.92% below its 200-day simple moving average ($1.51). Across its 52-week range of $0.68 to $2.50, AHG sits at the 35.7% percentile with a 14-day RSI of 53.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.16 to $1.50).